Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
AmpliPhi Biosciences Corp, Medical Devices Deals, 2012 to YTD 2018 10
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
AmpliPhi Biosciences Acquires Certain Bacteriophage Assets from Novolytics 13
Partnerships 14
AmpliPhi Biosciences to Enter into Agreement with WSLHD and Westmead Institute for Medical Research 14
AmpliPhi Biosciences Enters into Cooperative Research and Development Agreement with US Department of Veterans 15
AmpliPhi Biosciences Enters into Agreement with University of Adelaide 16
AmpliPhi BioSciences Enters Into R&D Agreement With U.S. Army Medical Research and Materiel Command And Walter Reed Army Institute of Research 17
Licensing Agreements 18
AmpliPhi Biosciences Enters into License Agreement with Takara Bio 18
AmpliPhi Enters into Licensing Agreement with University of Leicester 19
Equity Offering 20
AmpliPhi Biosciences Raises USD6.8 Million in Public Offering of Shares 20
AmpliPhi Biosciences Raises USD3 Million in Private Placement of Shares 22
AmpliPhi Biosciences Raises USD4 Million in Public Offering of Shares 23
AmpliPhi Biosciences Files Registration Statement for Public Offering of Shares 24
AmpliPhi Biosciences Raises USD10.6 Million in Public Offering of Shares 25
AmpliPhi Biosciences Raises USD4 Million in Public Offering of Shares and Warrants 27
AmpliPhi BioSciences Raises USD5 Million in Public Offering of Shares and Warrants 29
AmpliPhi BioSciences Raises USD13 Million in Private Placement of Shares 31
AmpliPhi Biosciences Completes Private Placement Of Shares For US$18 Million 32
AmpliPhi Biosciences Completes Private Placement Of Shares For US$7 Million 33
Debt Offering 35
Ampliphi Biosciences Completes Private Placement Of Notes For US$0.5 Million 35
Acquisition 36
AmpliPhi Biosciences Completes Acquisition Of Special Phage, Developer Of Anti-Bacterial Therapies 36
AmpliPhi Biosciences Corp – Key Competitors 37
AmpliPhi Biosciences Corp – Key Employees 38
AmpliPhi Biosciences Corp – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Aug 09, 2018: AmpliPhi Biosciences reports second quarter 2018 financial results and business highlights 40
May 15, 2018: AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights 41
Mar 14, 2018: AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights 42
Nov 14, 2017: AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights 43
Aug 14, 2017: AmpliPhi Biosciences Reports Second Quarter 2017 Financial Results and Business Highlights 44
May 15, 2017: AmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights 46
Mar 27, 2017: AmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights 48
Corporate Communications 50
May 31, 2017: AmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer 50
Jan 30, 2017: AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer 51
Government and Public Interest 52
Sep 06, 2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive 52
Product News 53
01/03/2018: AmpliPhi Biosciences Announces Positive Interim Results for Single-Patient Expanded Access Program Utilizing AB-SA01 53
Clinical Trials 54
Sep 11, 2017: AmpliPhi Biosciences Announces First Intravenous Treatment of a Patient with AB-SA01 Targeting Staphylococcus aureus 54
Apr 17, 2017: AmpliPhi Biosciences Announces Positive Feedback from FDA on Phase 2 Development Proposal 55
Apr 04, 2017: AmpliPhi Biosciences Presents Clinical and Preclinical Data of Pipeline Program AB-SA01 at Two Scientific Conferences 56
Other Significant Developments 57
Dec 14, 2017: AmpliPhi Biosciences Provides Corporate and Strategic Update 57
May 01, 2017: AmpliPhi Biosciences Announces a New Strategic Emphasis on Personalized Therapies for Serious or Life-Threatening Antibiotic-Resistant Infections 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AmpliPhi Biosciences Corp, Deals By Therapy Area, 2012 to YTD 2018 9
AmpliPhi Biosciences Corp, Medical Devices Deals, 2012 to YTD 2018 10
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
AmpliPhi Biosciences Acquires Certain Bacteriophage Assets from Novolytics 13
AmpliPhi Biosciences to Enter into Agreement with WSLHD and Westmead Institute for Medical Research 14
AmpliPhi Biosciences Enters into Cooperative Research and Development Agreement with US Department of Veterans 15
AmpliPhi Biosciences Enters into Agreement with University of Adelaide 16
AmpliPhi BioSciences Enters Into R&D Agreement With U.S. Army Medical Research and Materiel Command And Walter Reed Army Institute of Research 17
AmpliPhi Biosciences Enters into License Agreement with Takara Bio 18
AmpliPhi Enters into Licensing Agreement with University of Leicester 19
AmpliPhi Biosciences Raises USD6.8 Million in Public Offering of Shares 20
AmpliPhi Biosciences Raises USD3 Million in Private Placement of Shares 22
AmpliPhi Biosciences Raises USD4 Million in Public Offering of Shares 23
AmpliPhi Biosciences Files Registration Statement for Public Offering of Shares 24
AmpliPhi Biosciences Raises USD10.6 Million in Public Offering of Shares 25
AmpliPhi Biosciences Raises USD4 Million in Public Offering of Shares and Warrants 27
AmpliPhi BioSciences Raises USD5 Million in Public Offering of Shares and Warrants 29
AmpliPhi BioSciences Raises USD13 Million in Private Placement of Shares 31
AmpliPhi Biosciences Completes Private Placement Of Shares For US$18 Million 32
AmpliPhi Biosciences Completes Private Placement Of Shares For US$7 Million 33
Ampliphi Biosciences Completes Private Placement Of Notes For US$0.5 Million 35
AmpliPhi Biosciences Completes Acquisition Of Special Phage, Developer Of Anti-Bacterial Therapies 36
AmpliPhi Biosciences Corp, Key Competitors 37
AmpliPhi Biosciences Corp, Key Employees 38
AmpliPhi Biosciences Corp, Other Locations 39
AmpliPhi Biosciences Corp, Subsidiaries 39
List of Figures
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
AmpliPhi Biosciences Corp, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer